EDGE Product Development Helps Innovative BioSensors, Inc. take MIT Technology to Market

Newtown, PA, March 15, 2008 – Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, recently announced that it has launched the BioFlash® Biological Aerosol Collection, Detection and Identification System.

IBI teamed up with EDGE for the design and engineering effort to help IBI “productize” the CANARY™ biosensor technology developed at Massachusetts Institute of Technology (MIT) Lincoln Laboratory. EDGE worked closely with IBI marketing and research and development organization to design, engineer, prototype and test the BioFlash® System to product specifications and market requirements.

“EDGE helps companies transform emerging technologies into innovative products,” said Dan Doorley, President and CEO of EDGE. “For IBI, we leveraged our design and comprehensive engineering experience developing bio-chem detection systems in homeland security and life sciences instrumentation to help IBI launch the BioFlash® System.”

About EDGE Product Development Corporation

EDGE is a privately held ISO 9001 certified, full-service product design and engineering firm specializing in supporting early stage and industry leaders develop new products and devices for the military/security, commercial and medical markets. With our multi-discipline, integrated product development team approach, and over twenty years of innovation experience, EDGE is the ideal partner to transform emerging technologies into products. Additional information is available at www.edge-pdc.com

Contact:
Doreen LaBonge
Marketing Coordinator
EDGE pdc
215.579.5700